Morgan Stanley increased its ratings for tTeva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) from “Underweight” to “Equal Weight” in a report published on Friday. Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) shares after opening at $49.37 moved to $50.20 on last trade day and at the end of the day closed at $49.91. Company price to sales ratio in past twelve months was calculated as 2.02 and price to cash ratio as 40.73.Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) showed a positive weekly performance of 1.32%.
BancorpSouth, Inc.(NYSE:BXS) also recently announced a quarterly dividend, which is scheduled for Tuesday, April 1st. Investors of record on Friday, March 14th will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.81%. The ex-dividend date is Wednesday, March 12th. BancorpSouth, Inc.(NYSE:BXS) shares advanced 0.84% in last trading session and ended the day on $25.21. BXS return on equity ratio is recorded as 6.40% and its return on assets is 0.70%.BancorpSouth, Inc.(NYSE:BXS) yearly performance is 59.15%.
BG Medicine, Inc. (NASDAQ:BGMD) shares have been showing positive movement from the last few days. The stock rose nearly 36 percent in the past five days. BG Medicine, Inc. (NASDAQ:BGMD) shares moved up 31.21% in last trading session and was closed at $1.85 while trading in range of $1.46 – 1.87 .BG Medicine,Inc. (NASDAQ:BGMD) year to date (YTD) performance is 77.88%.BGMedicine,Inc.(NASDAQ:BGMD) weekly performance is 48.00%.BG Medicine,Inc.(NASDAQ:BGMD) distance from 50-day simple moving average(SMA50)43.95%. Analysts mean target price for the company is $1.50.
Bristol-Myers Squibb & Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced that the FDA has approved an additional indication of Bristol’s anti-blood clot medicine, Eliquis. Pfizer Inc. (NYSE:PFE) stock performance was 0.35% in last session and finished the day at $31.23. Traded volume was 27.11 million shares in the last session and the average volume of the stock remained 27.87 million shares. The beta of the stock remained 0.67. Pfizer Inc. (NYSE:PFE) insider ownership is 0.10%. Bristol-Myers Squibb Co(NYSE:BMY) weekly performance is -1.97%. On last trading day company shares ended up $54.73. Bristol-Myers Squibb Co(NYSE:BMY) distance from 50-day simple moving average (SMA50) is 2.59%. Analysts mean target price for the company is $55.06.